Reduced CD 5 + CD 24 hi CD 38 hi and interleukin‐10 + regulatory B cells in active anti‐neutrophil cytoplasmic autoantibody‐associated vasculitis permit increased circulating autoantibodies
Author(s) -
Aybar L. T.,
McGregor J. G.,
Hogan S. L.,
Hu Y.,
Mendoza C. E.,
Brant E. J.,
Poulton C. J.,
Henderson C. D.,
Falk R. J.,
Bunch D. O.
Publication year - 2015
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.12483
Subject(s) - autoantibody , immunology , vasculitis , medicine , autoimmunity , antibody , pathology , disease
Summary Pathogenesis of anti‐neutrophil cytoplasmic autoantibody (ANCA) ‐associated vasculitis is B cell‐dependent, although how particular B cell subsets modulate immunopathogenesis remains unknown. Although their phenotype remains controversial, regulatory B cells ( B regs ), play a role in immunological tolerance via interleukin ( IL) ‐10. Putative CD 19 + CD 24 hi CD 38 hi and CD 19 + CD 24 hi CD 27 + B regs were evaluated in addition to their CD 5 + subsets in 69 patients with ANCA‐associated vasculitis (AAV) . B cell IL ‐10 was verified by flow cytometry following culture with CD 40 ligand and cytosine–phosphate–guanosine ( CpG) DNA . Patients with active disease had decreased levels of CD 5 + CD 24 hi CD 38 hi B cells and IL‐ 10 + B cells compared to patients in remission and healthy controls ( HC s). As IL ‐10 + and CD 5 + CD 24 hi CD 38 hi B cells normalized in remission within an individual, ANCA titres decreased. The CD 5 + subset of CD 24 hi CD 38 hi B cells decreases in active disease and rebounds during remission similarly to IL ‐10‐producing B cells. Moreover, CD 5 + B cells are enriched in the ability to produce IL ‐10 compared to CD 5 neg B cells. Together these results suggest that CD 5 may identify functional IL ‐10‐producing B regs . The malfunction of B regs during active disease due to reduced IL ‐10 expression may thus permit ANCA production.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom